Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety and Efficacy of Repetitive Erythropoietin Treatment for Cerebral Palsy

NCT03303573 is registered in ClinicalTrials.gov with Bundang CHA Hospital as lead sponsor.

NCT NCT03303573
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03303573 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety and Efficacy of Repetitive Erythropoietin Treatment for Cerebral Palsy
Lead sponsor
Bundang CHA Hospital
Phase
Observational
Overall status
Completed
Start date
January 1, 2013
Completion date
August 31, 2017
Enrollment
164 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

cerebral palsy